upcoming glp-1 drugs From 'companion foods' to 'Nature's Ozempic.' Big food & Lilly is now pharma's top
Description
Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: A systematic review and meta-analysis
, ,
"I'm partnering with Ro because if I needed help as a top athlete doing everything at level 10, I know others are struggling too, and everyone deserves access to the treatment they need
The focus of the current study was to therefore, examine the efficacy of GLP-1 SSM in ameliorating DSS induced colitis and the associated diarrheal phenotype
